Harvard Bioscience Inc. completed the acquisition of Data Sciences International Inc. for about $70 million, subject to adjustment for net working capital and other customary adjustments.
Harvard Bioscience acquires Data Sciences for $70M
A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research
2021 Year in Review: Highlighting Key Investment Banking Trends
Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings
Global M&A By the Numbers: Q3 2021
Harvard Bioscience acquires Data Sciences for $70M
- Author Mirza Salam Ahmed
- Theme Healthcare & Pharmaceuticals
- Author
- Mirza Salam Ahmed
- Theme
- Healthcare & Pharmaceuticals
